2012 - 2009

1. Müller A, Münch D, Schmidt Y, Reder-Christ K, Schiffer G, Bendas G, Gross H, Sahl HG, Schneider T, Brötz-Oesterhelt H. The lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursors. 2012. J Biol Chem.
2. Arndts K, Deininger S, Specht S, Klarmann U, Mand S, Adjobimey T, Debrah AY, Batsa L, Kwarteng A, Epp C, Taylor M, Adjei O, Layland LE, Hoerauf A. Elevated Adaptive Immune Responses Are Associated with Latent Infections of Wuchereria bancrofti. 2012. PLoS Negl Trop Dis. 6(4):e1611.
3. Haas J, Bekeredjian-Ding I, Milkova M, Balint B, Schwarz A, Korporal M, Jarius S, Fritz B, Lorenz HM, Wildemann B. 2011. B cells undergo unique compartmentalized redistribution in multiple sclerosis. J Autoimmun. 37(4):289-99.
4. Sass P, Berscheid A, Jansen A, Oedenkoven M, Szekat C, Strittmatter A, Gottschalk G, Bierbaum G. 2012. Genome Sequence of Staphylococcus aureus VC40, a Vancomycin- and Daptomycin-Resistant Strain, To Study the Genetics of Development of Resistance to Currently Applied Last-Resort Antibiotics. J Bacteriol. 194(8):2107-8.
5. Müller A, Ulm H, Reder-Christ K, Sahl HG, Schneider T. 2012. Interaction of Type A Lantibiotics with Undecaprenol-Bound Cell Envelope Precursors. Microb Drug Resist.
6. Berscheid A, Sass P, Weber-Lassalle K, Cheung AL, Bierbaum G. 2012. Revisiting the genomes of the Staphylococcus aureus strains NCTC 8325 and RN4220. Int J Med Microbiol.
7. Ziewer S, Hübner MP, Dubben B, Hoffmann WH, Bain O, Martin C, Hoerauf A, Specht S. 2012. Immunization with L. sigmodontis Microfilariae Reduces Peripheral Microfilaraemia after Challenge Infection by Inhibition of Filarial Embryogenesis. PLoS Negl Trop Dis. 6(3):e1558.
8. Mischnik A, Zimmermann S, Bekeredjian-Ding I, Egermann M. 2012. Relapse of posttraumatic osteomyelitis due to Clostridium celerecrescens. Infection. 39(5):491-4.
9. Hübner MP, Shi Y, Torrero MN, Mueller E, Larson D, Soloviova K, Gondorf F, Hoerauf A, Killoran KE, Stocker JT, Davies SJ, Tarbell KV, Mitre E. 2012. Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β. J Immunol. 188(2):559-68.
10. Tendongfor N, Wanji S, Ngwa JC, Esum ME, Specht S, Enyong P, Matthaei KI, Hoerauf A. 2012. The human parasite Loa loa in cytokine and cytokine receptor gene knock out BALB/c mice: survival, development and localization. Parasit Vectors 5(1):43.
11. Münch D, Roemer T, Lee SH, Engeser M, Sahl HG, Schneider T. 2012. Identification and in vitro Analysis of the GatD/MurT Enzyme-Complex Catalyzing Lipid II Amidation in Staphylococcus aureus. PLoS Pathog. 8(1):e1002509.
12. Islam MR, Nishie M, Nagao JI, Zendo T, Keller S, Nakayama J, Kohda D, Sahl HG, Sonomoto K. 2012. Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic. J Am Chem Soc.
13. Mand S, Debrah AY, Klarmann U, Mante S, Kwarteng A, Batsa L, Marfo-Debrekyei Y, Adjei O, Hoerauf A. 2011. The role of ultrasonography in the differentiation of the various types of filaricele due to bancroftian filariasis. Acta Trop. 120 Suppl 1:S23-32.
14. Kumar S, Singh S, Hinze D, Josten M, Sahl HG, Siepmann M, Walter J. 2012. Phosphorylation of the amyloid-β peptide at serine 8 attenuates its clearance via insulin degrading and angiotensin converting enzymes. J Biol Chem.
15. Türck M, Bierbaum G. 2012. Purification and Activity Testing of the Full-Length YycFGHI Proteins of Staphylococcus aureus. PLoS One. 7(1):e30403.
16. Arnusch CJ, Albada HB, van Vaardegem M, Liskamp RM, Sahl HG, Shadkchan Y, Osherov N, Shai Y. 2012. Trivalent Ultrashort Lipopeptides are Potent pH Dependent Antifungal Agents. J Med Chem.
17. Albers A, Esum ME, Tendongfor N, Enyong P, Klarmann U, Wanji S, Hoerauf A, Pfarr K. 2012. Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host. Parasit Vectors.
18. Herzner AM, Dischinger J, Szekat C, Josten M, Schmitz S, Yakéléba A, Reinartz R, Jansen A, Sahl HG, Piel J, Bierbaum G. 2011. Expression of the lantibiotic mersacidin in Bacillus amyloliquefaciens FZB42. PLoS One 6(7):e22389.
19. Schmidt KE, Schumak B, Specht S, Dubben B, Limmer A, Hoerauf A. 2011. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner. Microbes Infect 13(10):828-36.
20. Liesenfeld O, Parvanova I, Zerrahn J, Han SJ, Heinrich F, Muñoz M, Kaiser F, Aebischer T, Buch T, Waisman A, Reichmann G, Utermöhlen O, von Stebut E, von Loewenich FD, Bogdan C, Specht S, Saeftel M, Hoerauf A, Mota MM, Könen-Waisman S, Kaufmann SH, Howard JC. 2011. The IFN-γ-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens. PLoS One 6(6):e20568.
21. Brattig NW, Racz P, Hoerauf A, Büttner DW. 2011. Strong expression of TGF-beta in human host tissues around subcutaneous Dirofilaria repens. Parasitol Res 108(6):1347-54.
22. Gaballah A, Kloeckner A, Otten C, Sahl HG, Henrichfreise B. 2011. Functional Analysis of the Cytoskeleton Protein MreB from Chlamydophila pneumoniae. PLoS One 6(10):e25129.
23. Arnusch CJ, Ulm H, Josten M, Shadkchan Y, Osherov N, Sahl HG, Shai Y. 2011 Ultrashort Peptide Bioconjugates are Exclusively Antifungal Agents and Synergize with Cyclodextrin and Amphotericin B. Antimicrob Agents Chemother. 55(3):1296-302.
24. Sass P, Josten M, Famulla K, Schiffer G, Sahl HG, Hamoen L, Brötz-Oesterhelt H. 2011. Antibiotic acyldepispeptides activate ClpP peptidase to degrade the cell division protein FtsZ. PNAS 108(42):17474-9.
25. Specht S, Taylor MD, Hoeve M, Allen JE, Lang R, Hoerauf A. 2011. Over expression of IL-10 by macrophages overcomes resistance to murine filariasis. Exp Parasitol.
26. Debrah AY, Batsa L, Albers A, Mand S, Toliat MR, Nürnberg P, Adjei O, Hoerauf A, Pfarr K. 2011. Transforming growth factor-ß1 variant Leu10Pro is associated with both lack of microfilariae and differential microfilarial loads in the blood of persons infected with lymphatic filariasis. Hum Immunol. 72(11):1143-8.
27. Hübner MP, Larson D, Torrero MN, Mueller E, Shi Y, Killoran KE, Mitre E. 2011. Anti-FceR1 antiobdy injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice. Clin Immunol.
28. Sass P, Josten M, Famulla K, Schiffer G, Sahl HG, Hamoen L, Brötz-Oesterhelt H. 2011. Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ. Proc Natl Acad Sci USA.
29. Ma Y, Muench D, Schneider T, Sahl HG, Bouhss A, Ghoshdastider U, Wang J, Doetsch V, Wang X, Bernhard F. 2011. Preparative scale cell-free production and quality optimization of MraY homologues in different expression modes. J Biol Chem.
30. Reder-Christ K, Schmidt Y, Dörr M, Sahl HG, Josten M, Raaijmakers JM, Gross H, Bendas G. 2012. Model membrane studies for characterization of different antibiotic activities of lipopeptides from Pseudomonas. Biochim Biophys Acta. 1818(3):566-73.
31. Tamarozzi F, Halliday A, Gentil K, Hoerauf A, Pearlman E, Taylor MJ. 2011. Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis and treatment. Clin Microbiol Rev 23(3):459-468.
32. Herzner AM, Dischinger J, Szekat C, Josten M, Schmitz S, Yakéléba A, Reinartz R, Jansen A, Sahl HG, Piel J, Bierbaum G. 2011. Expression of the lantibiotic mersacidin in Bacillus amyloliquefaciens FZB42. PLoS One 6(7):e22389.
33. Hoerauf A, Pfarr K, Mand S, Debrah AY, Specht S. 2011. Filariasis in Africa - treatment challenges and prospects. Clin Microbiol Infect 17(7):977-85.
34. Heinrich N, Mueller A, Bartmann P, Simon A, Bierbaum G, Engelhart S. 2011. Successful management of an MRSA outbreak in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis 30(7):909-13.
35. Wilmes M, Cammue BP, Sahl HG, Thevissen K. 2011. Antbiotic activities of host defense peptides: more to it than lipid bilayer perturbation. Nat Prod Rep 28(8):1350-8.
36. Teran R, Mitre E, Vaca M, Erazo S, Oviedo G, Hübner MP, Chico ME, Matapallil JJ, Bickle Q, Rodrigues LC, Cooper PJ. 2011. Immune system development during early childhood in tropical Latin America: evidence for the age-dependent down regulation of the innate immune response. Clin Immunol 138(3):199-310.
37. Nagel M, Reuter T, Jansen A, Szekat C, Bierbaum G. 2011. Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus. Int J Med Microbiol 301(3):229-36.
38. Liesenfeld O, Parvanova I, Zerrahn J, Han SJ, Heinrich F, Muñoz M, Kaiser F, Aebischer T, Buch T, Waisman A, Reichmann G, Utermöhlen O, von Stebut E, von Loewenich FD, Bogdan C, Specht S, Saeftel M, Hoerauf A, Mota MM, Könen-Waisman S, Kaufmann SH, Howard JC. 2011. The IFNy-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens. PLoS One 6(6):e20568.
39. Rubinchik E, Schneider T, Elliott M, Scott WR, Pan J, Anklin C, Yang H, Dugourd D, Müller A, Gries K, Straus SK, Sahl HG, Hancock RE. 2011. Mechanism of action and limited cross-resistance of new lipopeptide MX-2401. Antimicrob Agents Chemother 55(6):2743-54.
40. Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Albers A, Specht S, Klarmann U, Pfarr K, Adjei O, Hoerauf A. 2011. Macrofilaricidal Activity in Wuchereria bancrofti after 2 Weeks Treatment with a Combination of Rifmapicin plus Doxycycline. J Parasitol Res 2011:201617.
41. Kusch P, Deininger S, Specht S, Maniako R, Haubrich S, Pommerening T, Lin PK, Hoerauf A, Kaiser A. 2011. In Vitro and In Vivo Antimalarial Activity Assays of Seeds from Balanites aegyptiaca: Compounds of the Extract Show Growth Inhibition and Activity against Plasmodial Aminopeptidase. J Parasitol Res 2011:268692.
42. Schmidt KE, Schumak B, Specht S, Dubben B, Limmer A, Hoerauf A. Induction of pro-inflammatory mediators in Plasmdoium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner. Microbes Infect 13(10):828-36.
43. Hussain H, Specht S, Sarite SR, Saeftel M, Hoerauf A, Schulz B, Krohn K. 2011. A new class of phenazines with activity against a chloroquine resistant Plasmodium falciparum strain and antimicrobial activity. J Med Chem 54(13):4913-7.
44. Brattig NW, Racz P, Hoerauf A. Büttner DW. 2011. Strong expression of TGF-beta in human host tissues around subcutaneous Dirofilaria repens. Parasitol Res 108(6):1347-54.
45. Elsebai MF, Kehraus S, Lindequist U, Sasse F, Shaaban S, Gütschow M, Josten M, Sahl HG, König GM. 2011. Antimicrobial phenalenone derivatives from the marine-derived fungus Coniothyrium cereale. Org Biomol Chem 9(3):802-8.
46. Specht S, Frank JK, Alferink J, Dubben B, Layland LE, Denece G, Bain O, Förster I, Kirschning CJ, Martin C, Hoerauf A. 2011. CCL17 controls mast cells for the defense against filarial larval entry. J Immunol 186(8):4845-52.
47. Hoerauf A. 2010. Microflora, helminths and the immune system - who controls whom? N Engl J Med 363(15):1476-8.
48. Adjobimey T, Hoerauf A. 2010. Induction of immunoglobulin G4 in human filariasis: an indicator of immunoregulation. Ann Trop Med Parasitol 104(6):455-64.
49. Taylor MJ, Hoerauf A, Bockarie M. 2010. Lymphatic filariasis and onchocerciasis. Lancet 376(9747):1175-85.
50. Niebel B, Lentz C, Pofahl M, Mayer G, Hoerauf A, Pfarr KM, Famulok M. 2010. ADLOC: an aptamer-displacement assay based on luminescent oxygen channeling. Chemistry 16(36):11100-7.
51. Mand S, Debrah AY, Klarmann U, Mante S, Kwarteng A, Batsa L, Marfo-Debrekyei Y, Adjei O, Hoerauf A. 2010. The role of ultrasonography in the differentiation of the various types of filaricele due to bancroftian filariasis. Acta Trop.
52. Korten S, Hoerauf A, Kaifi JT, Büttner DW. 2011. Low levels of transforming growth factor-beta (TGF-beta) and reduced suppression of Th2-mediated inflammation in hyperreactive human onchocerciasis. Parasitology 138(1):35-45.
53. Brattig NW, Tenner-Racz K, Korten S, Hoerauf A, Büttner DW. 2010 Immunohistology of ectopic secondary lymph hfollicles in subcutaneous nodules from patients with hyperreactive onchocerciasis (sowda). Parasitol Res 107(3):657-66.
54. Appenrodt B, Lehmann LE, Thyssen L, Gentemann M, Rabe C, Molitor E, Trebicka J, Stüber F, Sauerbruch T. 2010. Is detection of bacterial DNA in ascitic fluid of clinical relevance= Eur J Gastroenterol Hepatol 22(12):1487-94.
55. Specht S, Ruiz DF, Dubben B, Deininger S, Hoerauf A. 2010. Filaria-induced IL-10 suppresses murine cerebral malaria. Microbes Infect 12(8-9):635-42.
56. Turner JD, Tendongfor N, Esum M, Johnston KL, Langley RS, Ford L, Faragher B, Specht S, Mand S, Hoerauf A, Enyong P, Wanji S, Taylor MJ. 2010. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled-trial. ÖLoS Negl Trop Dis 4(4):e660.
57. Portillo JA, Okenka G, Reed E, Subauste A; Van Grol J, Gentil K, Komatsu M, Tanaka K, Landreth G, Levine B, Subauste CS. 2010. The CD40-autophagy pathway is needed for host protection despite IFNy-dependent immunity and CD40 induces autophagy via control of P21 levels. PLoS One 5(12):e14472.
58. Schmitt P, Wilmes M, Pugnière M, Aumelas A, Bachère E, Sahl HG, Schneider T, Destoumieux-Garzón D. 2010. Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II. J Biol Chem 285(38):29208-16.
59. Strübing U, Lucius R, Hoerauf A, Pfarr KM. 2010. Mitochondrial genes for heme-dependent respiratory chain complexes are up-regulated after depletion of Wolbachia from filarial nematodes. Int J Parasitol 40(10):1193-202.
60. Korten S, Kaifi JT, Büttner DW, Hoerauf A. 2010. Transforming growth factor-beta expression by host cells is elicited locally by the filarial nematode Onchocerca volvulus in hyporeactive patients independently from Wolbachia. Microbes Infect 12(7):555-64.
61. Wansi JD, Hussain H, Tcho AT, Kouam SF, Specht S, Sarite SR, Hoerauf A, Krohn K. 2010. Antiplasmodial activities of furoquinoline alkaloids from Teclea afzelii. Phytother Res 24(5):775-7.
62. Torrero MN, Hübner MP, Larson D, Karasuyama H, Mitre E. 2010. Basophils amplify type 2 immune responses, but do not serve a protective role, during chronic infection of mice with the filarial nematode Litomosoides sigmodontis. J Immunol 185(12):7426-34.
63. Schneider T, Kruse T, Wimmer R, Wiedemann I, Sas V, Pag U, Jansen A, Nielsen AK, Mygind PH, Raventós DS, Neve S, Ravn B, Bonvin AM, De Maria L, Andersen AS, Gammelgaard LK, Sahl HG, Kristensen HH. 2010. Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 328(5982):1168-72.
64. Ritter M, Gross O, Kays S, Ruland J, Nimmerjahn F, Saijo S, Tschopp J, Layland LE, Prazeres da Costa C. 2010. Schistosoma mansoni triggers Dectin-2, which activates the Nlrp3 inflammasome and alters adaptive immune responses. Proc Natl Acad Sci USA 107(47):20459-64.
65. Hübner MP, Torrero MN, Mitre E. 2010. Type 2 immune-inducing helminth vaccination maintains protective efficacy in the setting of repeated parasite exposures. Vaccine 28(7):1746-57.
66. Rogosch T, Kerzel S, Sikula L, Gentil K, Liebetruth M, Schlingmann KP, Maier RF, Zemlin M. 2010. Plasma cells and nonplasma B cells express differing IgE repertoires in allergic sensitization. J Immunol 184(9):4947-54.
67. Liu J, Llius A, Illi S, Layland L, Olek S, von Mutius E, Schaub B. 2010. T regulatory cells in cord blood - FOXP3 demethylation as reliable quantitative marker. PLoS One 5(10):e13267.
68. Sass V, Schneider T, Wilmes M, Körner C, Tossi A, Novikova N, Shamova O, Sahl HG. 2010. Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci. Infect Immun 78(6):2793-800.
69. Langhans B, Braunschweiger I, Arndt S, Schulte W, Satoguina J, Layland LE, Vidovic N, Hoerauf A, Oldenburg J, Sauerbruch T, Spengler U. 2010. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C. Clin Sci (Lond) 119(2):97-109.
70. Brattig NW, Hoerauf A, Fischer PU, Liebau E, Bandi C, Debrah A, Büttner M, Büttner DW. 2010. Immunohistological studies on neoplasms of female and male Onchocerca volvulus: filarial origin and absence of Wolbachia from tumor cells. Parasitology 137(5):841-54.
71. Attout T, Hoerauf A, Dénécé G, Debrah AY, Marfo-Debrekyei Y, Boussinesq M, Wanji S, Martinez V, Mand S, Adjei O, Bain O, Specht S, Martin C. 2009. Lymphatic vascularisation and involvement of Lyve-1+ macrophages in the human onchocerca nodule. PLoS One 4(12):e8234.
72. Schäberle TF, Goralski E, Neu E, Erol O, Hölzl G, Dörmann P, Bierbaum G, König GM. 2010. Marine myxobacteria as a source of antibiotics - comparison of physiology, polyketide-type genes and antibiotic production of three new isolates of Enhygromyxa salina. Mar Drugs 8(9):2466-79.
73. Layland LE, Mages J, Loddenkemper C, Hoerauf A, Wagner H, Lang R, da Costa CU. 2010. Pronounced phenotype in activated regulatory T cells during a chronic helminth infection. J Immunol 184(2):713-24.
74. Schneider T, Sahl HG. 2010. Lipid II and other bactoprenol-bound cell wall precursors as drug targets. Curr Opin Inestig Drugs 11(2):157-64.
75. Schneider T, Sahl HG. 2010. An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway. Int J Med Microbiol 300(2-3):161-9.
76. Blavid R, Kusch P, Hauber J, Eschweiler U, Sarite SR, Specht S, Deininger S, Hoerauf A, Kaiser A. 2010. Down-regulation of hypusine biosynthesis in Plasmodium by inhibition of S-adenosyl-methionine-decarboxylase. Amino Acids 38(2):461-9.
77. Then RL, Sahl HG. 2010. Anti-infective strategies of the future: is there room for species-specific antibacterial agents? Curr Pharm Des 16(5):555-66.
78. Pfarr KM, Debrah AY, Specht S, Hoerauf A. 2009. Filariasis and lymphoedema. Parasite Immunol 31(11):664-72.
79. Mand S, Pfarr K, Sahoo PK, Satapathy AK, Specht S, Klarmann U, Debrah AY, Ravindran B, Hoerauf A. 2009. Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine. Am J Trop Med Hyg 82(4):702-11.
80. Prusseit J, Simon M, von der Brelie C, Heep A, Molitor E, Volz S, Simon A. 2009. Epidemiology, prevention and management of ventriculoperitoneal shunt infections in children. Pediatr Neurosurg 45(5):325-36.
81. Specht S, Brattig N, Büttner M, Büttner DW. 2009. Criteria for the differentiation between yound and old Onchocerca volvulus filariae. Parasitol Res 105(6):1531-8.
82. Hoerauf A. 2009. Mansonella perstans - the importance of an endosymbiont. N Engl J Med 361(15):1502-4.
83. Specht S, Hoerauf A, Adjei O, Debrah A, Büttner DW. 2009. Newly acquired Onchocerca volvulus filariae after doxycycline treatment. Parasitol Res 106(1):23-31.
84. Wanji S. Tendongfor N, Nji T, Esum M, Che JN, Nkwescheu A, Alassa F, Kamnang G, Enyong PA, Taylor MJ, Hoerauf A, Taylor DW. 2009 Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon. Parasit Vectors 2(1):39.
85. Henrichfreise B, Schiefer A, Schneider T, Nzukou E, Poellinger C, Hoffmann TJ, Johnston KL, Moelleken K, Wiedemann I, Pfarr K, Hoerauf A, Sahl HG. 2009. Functional conservation of the lipid II biosynthesis pathway in the cell wall-less bacteria Chlamydia and Wolbachia: why is lipid II needed? Mol Microbiol 73(5):913-23.
86. Pietiäinen M, François  P, Hyyryläinen HL, Tangomo M, Sass V, Sahl HG, Schrezel J, Kontinen VP. 2009. Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance. BMC Genomics 10:429.
87. Hübner MP, Torrero MN, McCall JW, Mitre E. 2009. Litomosoides sigmodontis: a simple method to infect mice with L3 larvae obtained from the pleural space of recently infected jirds (meriones unguiculatus). Exp Parasitol 123(1):95-8.
88. Torero MN, Larson D, Hübner MP, Mitre E. 2009. CD200R surface expression as a marker of murine basophil activation. Clin Exp Allergy 39(3):361-9.
89. Dischinger J, Josten M, Szekat C, Sahl HG, Bierbaum G. 2009. Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLoS One 4(8):e6788.
90. Hübner MP, Stocker JT, Mitre E. 2009. Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. Immunol 127(4):512-22.
91. Brattig NW, Schwohl A, Hoerauf A, Büttner DW. 2009. Identification of the lipid mediator prostaglandin E2 in tissue immune cells of humans infected with the filaria Onchocerca volvulus. Acta Trop 112(2):231-5.
92. Turner JD, Langley RS, Johnston KL, Gentil K, Ford L, Wu B, Graham M, Sharpley F, Slatko B, Pearlman E, Taylor MJ. 2009. Wolbachia lipoprotein stimulates inate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis. J Biol Chem 284(33):22364-78.
93. Griesbeck AG, Neudörfl J, Hörauf A, Specht S, Raabe A. 2009. Antimalarial peroxide dyads from natural artemisinin and hydroyalkylated 1,2,4-trioxanes. J Med Chem 52(10):3420-3.
94. Specht S, Wanji S. 2009. New insights into the biology of filarial infections. J Helminthol 83(2):199-202.
95. Marklein G, Josten M, Klanke U, Müller E, Horré R, Maier T, Wenzel T, Kostrzewa M, Bierbaum G, Hoerauf A, Sahl HG. 2009. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol 47(9):2912-7.
96. Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Lawson B, Taylor M, Adjei O, Hoerauf A. 2009. Reduction in levels of plasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline. Am J Trop Med Hyg. 80(6):956-63.
97. Korten S, Büttner DW, Schmetz C, Hoerauf A, Mand S, Brattig N. 2009. The nematode parasite Onchocerca volvulus generates the transforming growth factor-beta (TGF-beta). Parasitol Res 105(3):731-41.
98. Gentil K, Pearlman E. 2009. gamma interferon and interleukin-1 receptor 1 regulate neutrophil recruitment to the corneal stroma in a murine model of Onchocerca volvulus keratitis. Infect Immun 77(4):1606-12.
99. Antcheva N, Morgera F, Creatti L, Vaccari L, Pag U, Pacor S, Shai Y, Sahl HG, Tossi A. 2009. Artificial beta-defensin based on a minimal defensin template. Biochem J 421(3):435-47.
100. Reiter-Owona I, Grüner B, Frosch M, Hoerauf A, Kern P, Tappe D. 2009. Serological confirmatory testing of alveolar and cystic echinococcosis in clinical practice: results of a comparative study with commercialized and in-house assays. Clin Lab 55(1-2):41-8.
101. Böttiger T, Schneider T, Martínez B, Sahl HG, Wiedemann I. 2009. Influence of Ca(2+) ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif. Appl Environ Microbiol 75(13):4427-34.
102. Specht S, Hoerauf A. 2009. Filarial parasites in the postgenomic era. Expert Rev Anti Infect Ther 7(2):189-92.
103. Raafat D, Sahl HG. 2009. Chitosan and its antimicrobial potential - a critical literature survey. Microb Biotechnol 2(2):186-201.
104. Faulde MK, Hoffmann R, Fazilat KM, Hoerauf A. 2009. Epidemiology of Plasmodium falciparum and P. vivax malaria endemic in northern Afghanistan. J Egypt Soc Parasitol 38(3):679-92.
105. Appleyard AN, Choi S, Read DM, Lightfoot A, Boakes S, Hoffmann A, Chopra I, Bierbaum G, Rudd BA, Dawson MJ, Cortes J. 2009. Dissecting structural and functional diversity of the lantibiotic mersacidin. Chem Biol 16(5):490-8.
106. Faulde M, Schrader J, Heyl G, Hoerauf A. 2009. High efficacy of integrated preventive measures against zoonotic cutaneous leishmaniasis in northern Afghanistan, as revealed by Quantified Infection Rates. Acta Trop 110(1):28-34.
107. Schneider T, Gries K, Josten M, Wiedemann I, Pelzer S, Labischinski H, Sahl HG. 2009. The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate. Antmicrob Agents Chemother 53(4):1610-8.
108. Taylor MJ, Awadzi K, Basáñez MG, Biritwum N, Boakye D, Boatin B, Bockarie M, Churcher TS, Debrah A, Edwards G, Hoerauf A, Mand S, Matthews G, Osei-Atweneboana M, Prichard RK, Wanji S, Adjei O. 2009. Onchocerciasis Control: Vision for the Future from a Ghanian perspective. Parasit Vectors 2(1):7.
109. Bierbaum G, Sahl HG. 2009. Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol 10(1):2-18.
110. Sass P, Bierbaum G. 2009. Native graS mutation supports the susceptibility of Staphylococcus aureus strain SG511 to antimicrobial peptides. Int J Med Microbiol 299(5):313-22.
111. Fernández Ruiz D, Dubben B, Saeftel M, Endl E, Deininger S, Hoerauf A, Specht S. 2009. Filarial infection induces protection against P. berghei liver stages in mice. Microbes Infect 11(2):172-80.
112. Hoerauf A, Specht S, Marfo-Debrekyei Y, Büttner M, Debrah AY, Mand S, Batsa L, Brattig N, Konadu P, Bandi C, Fimmers R, Adjei O, Büttner DW. 2009. Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus. Parasitol Res 104(2):437-47.